Exchange Traded Concepts’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Sell |
4,487
-156
| -3% | -$44.8K | 0.02% | 577 |
|
|
2025
Q1 | $1.43M | Buy |
4,643
+581
| +14% | +$179K | 0.02% | 453 |
|
|
2024
Q4 | $1.43M | Sell |
4,062
-74
| -2% | -$26.1K | 0.03% | 461 |
|
|
2024
Q3 | $1.48M | Sell |
4,136
-1,162
| -22% | -$416K | 0.03% | 410 |
|
|
2024
Q2 | $1.69M | Sell |
5,298
-634
| -11% | -$202K | 0.04% | 341 |
|
|
2024
Q1 | $1.36M | Buy |
5,932
+3,187
| +116% | +$732K | 0.04% | 370 |
|
|
2023
Q4 | $604K | Buy |
2,745
+210
| +8% | +$46.2K | 0.02% | 554 |
|
|
2023
Q3 | $573K | Sell |
2,535
-119
| -4% | -$26.9K | 0.02% | 545 |
|
|
2023
Q2 | $586K | Buy |
2,654
+105
| +4% | +$23.2K | 0.01% | 550 |
|
|
2023
Q1 | $571K | Sell |
2,549
-284
| -10% | -$63.6K | 0.02% | 520 |
|
|
2022
Q4 | $788K | Buy |
2,833
+75
| +3% | +$20.9K | 0.02% | 340 |
|
|
2022
Q3 | $577K | Sell |
2,758
-229
| -8% | -$47.9K | 0.02% | 403 |
|
|
2022
Q2 | $704K | Buy |
2,987
+68
| +2% | +$16K | 0.02% | 354 |
|
|
2022
Q1 | $524K | Buy |
2,919
+86
| +3% | +$15.4K | 0.01% | 626 |
|
|
2021
Q4 | $612K | Sell |
2,833
-160
| -5% | -$34.6K | 0.01% | 526 |
|
|
2021
Q3 | $552K | Buy |
2,993
+49
| +2% | +$9.04K | 0.01% | 503 |
|
|
2021
Q2 | $528K | Sell |
2,944
-154
| -5% | -$27.6K | 0.02% | 522 |
|
|
2021
Q1 | $518K | Sell |
3,098
-101
| -3% | -$16.9K | 0.02% | 453 |
|
|
2020
Q4 | $486K | Buy |
3,199
+313
| +11% | +$47.6K | 0.02% | 366 |
|
|
2020
Q3 | $291K | Buy |
2,886
+178
| +7% | +$17.9K | 0.02% | 478 |
|
|
2020
Q2 | $328K | Buy |
+2,708
| New | +$328K | 0.05% | 304 |
|